Showing results (141-150 of 160) with videos related to
Sort By:
Pageof 16
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 3, 2018
A model combining age, equivalent uniform dose and IL-8 may predict radiation esophagitis in patients with non-small cell lung cancerShulian Wang, Jeff Campbell, Matthew H Stenmark, et al.Journal of Oncology Practice|March 5, 2015
Wide Variation in the Diffusion of a New Technology: Practice-Based Trends in Intensity-Modulated Radiation Therapy (IMRT) Use in the State of Michigan, With Implications for IMRT Use NationallyDean A Shumway, Kent A Griffith, Lori J Pierce, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2015
Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular CarcinomaDaniel R Wahl, Matthew H Stenmark, Yebin Tao, et al.International Journal of Radiation Oncology, Biology, Physics|June 6, 2017
Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation StudyShulian Wang, Jeff Campbell, Matthew H Stenmark, et al.Oncogene|April 19, 2011
SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesisG E Lind, C Raiborg, S A Danielsen, et al.The Plant Cell|February 28, 2001
Trafficking of phosphatidylinositol 3-phosphate from the trans-Golgi network to the lumen of the central vacuole in plant cellsD H Kim, Y J Eu, C M Yoo, et al.Advances in Radiation Oncology|July 26, 2017
Priority-driven plan optimization in locally advanced lung patients based on perfusion SPECT imagingMartha M Matuszak, Charles Matrosic, David Jarema, et al.International Journal of Radiation Oncology, Biology, Physics|September 1, 2012
Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapyMatthew H Stenmark, Xu-Wei Cai, Kerby Shedden, et al.Cancer|August 16, 2012
The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancerMark Shilkrut, Gregory S Merrick, P William McLaughlin, et al.Translational Oncology|August 3, 2013
Stereotactic body radiation therapy for primary and metastatic liver tumorsErqi Liu, Matthew H Stenmark, Matthew J Schipper, et al.Pageof 16